Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease
Survey findings released in advance of World Lupus Day on May 10
According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
The data driven fertility company helps increase the success rate of fertility treatments
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Subscribe To Our Newsletter & Stay Updated
